A detailed history of Claro Advisors LLC transactions in Novartis Ag stock. As of the latest transaction made, Claro Advisors LLC holds 4,638 shares of NVS stock, worth $481,470. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,638
Previous 9,755 52.46%
Holding current value
$481,470
Previous $1.12 Million 52.5%
% of portfolio
0.08%
Previous 0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$106.13 - $120.89 $543,067 - $618,594
-5,117 Reduced 52.46%
4,638 $533,000
Q3 2024

Oct 17, 2024

BUY
$106.13 - $120.89 $1.04 Million - $1.18 Million
9,755 New
9,755 $1.12 Million
Q2 2022

Aug 12, 2022

BUY
$80.52 - $93.75 $147,190 - $171,375
1,828 Added 63.76%
4,695 $397,000
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $6,136 - $6,786
-77 Reduced 2.62%
2,867 $251,000
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $19,872 - $23,119
243 Added 9.0%
2,944 $241,000
Q2 2021

Aug 13, 2021

SELL
$85.24 - $94.15 $85 - $94
-1 Reduced 0.04%
2,701 $246,000
Q1 2021

May 17, 2021

BUY
$83.5 - $98.47 $15,865 - $18,709
190 Added 7.56%
2,702 $231,000
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $52,150 - $63,079
-668 Reduced 21.01%
2,512 $237,000
Q3 2020

Nov 16, 2020

BUY
$82.14 - $91.0 $8,788 - $9,737
107 Added 3.48%
3,180 $277,000
Q2 2020

Aug 14, 2020

BUY
$80.93 - $91.1 $24,359 - $27,421
301 Added 10.86%
3,073 $268,000
Q1 2020

May 15, 2020

BUY
$70.67 - $99.01 $20,423 - $28,613
289 Added 11.64%
2,772 $229,000
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $3,711 - $4,196
44 Added 1.8%
2,483 $235,000
Q3 2019

Oct 29, 2019

BUY
$85.54 - $94.26 $5,560 - $6,126
65 Added 2.74%
2,439 $212,000
Q2 2019

Jul 24, 2019

SELL
$75.4 - $92.8 $6,107 - $7,516
-81 Reduced 3.3%
2,374 $217,000
Q1 2019

May 10, 2019

BUY
$75.32 - $86.15 $76,073 - $87,011
1,010 Added 69.9%
2,455 $236,000
Q4 2018

Feb 14, 2019

BUY
$73.66 - $82.02 $106,438 - $118,518
1,445 New
1,445 $125,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Claro Advisors LLC Portfolio

Follow Claro Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claro Advisors LLC with notifications on news.